Not applicableLooking for participantsNCT07222436What this trial is testingCirculating Tumor DNA in High Risk Localized Prostate CancerWho this might be right forProstate Cancer University of Pittsburgh 24
Not applicableActive Not RecruitingNCT02918253What this trial is testingHDR Focal: Feasibility StudyWho this might be right forProstate Cancer University Health Network, Toronto 60
Early research (Phase 1)Active Not RecruitingNCT04486755What this trial is testingHypofractionated Accelerated Pelvic Nodal Radiotherapy (GCC 2048)Who this might be right forProstate CancerProstate Adenocarcinoma University of Maryland, Baltimore 18
Large-scale testing (Phase 3)Active Not RecruitingNCT02531516What this trial is testingAn Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLASWho this might be right forProstatic Neoplasms Aragon Pharmaceuticals, Inc. 1,503
Not applicableUnknownNCT04278261What this trial is testingComparison H-FIRE and Laparoscopic RP in Treating Men With Localized Prostate CancerWho this might be right forProstate CancerTreatment Shanghai East Hospital 216
Testing effectiveness (Phase 2)Study completedNCT03263780What this trial is testingHigh Resolution PET-MRI Before Prostate Cancer HIFUWho this might be right forProstate Cancer Timothy J. Daskivich 21
Not applicableUnknownNCT02290561What this trial is testingSmartTarget THERAPYWho this might be right forProstatic Neoplasms University College, London 69
Not applicableNot Yet RecruitingNCT07407686What this trial is testingImproving Engagement From Underserved Communities With Prostate Cancer Genetics ServicesWho this might be right forProstate Cancer Royal Marsden NHS Foundation Trust 100
Testing effectiveness (Phase 2)UnknownNCT00988130What this trial is testingHigh-Intensity Focused Ultrasound Focal Ablation in Treating Patients With Progressive Prostate CancerWho this might be right forProstate CancerSexual Dysfunction University College London Hospitals 26
Testing effectiveness (Phase 2)Ended earlyNCT00924807What this trial is testingSafety Study of Sorafenib With Androgen Deprivation and Radiotherapy to Treat Prostate CancerWho this might be right forProstate Cancer Beth Israel Medical Center 4
Not applicableStudy completedNCT01123434What this trial is testingImmediate Postoperative Adjuvant Hormonal Treatment in High Risk Localised or Locally Advanced Prostate Cancer Patients.Who this might be right for2 Years PSA Recurrence Rate AstraZeneca 200
Testing effectiveness (Phase 2)Looking for participantsNCT05361798What this trial is testingA Phase II Study Evaluating T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine PDS01ADC in Localized High and Intermediate Risk Prostate Cancer Treated With Androgen Deprivation TherapyWho this might be right forCancer Of Prostate National Cancer Institute (NCI) 65
Testing effectiveness (Phase 2)Looking for participantsNCT06347705What this trial is testing2141-V11 in Combination With Standard Treatments in People With Prostate CancerWho this might be right forProstate Cancer Memorial Sloan Kettering Cancer Center 57
Not applicableNot Yet RecruitingNCT07126093What this trial is testingHigh-intensity Focused Ultrasound Combined With Novel Hormone Therapy in Advanced Prostate CancerWho this might be right forProstate Cancer Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 134
Not applicableLooking for participantsNCT06270043What this trial is testingFocal Therapy for Localized Prostate CancerWho this might be right forProstate Cancer University of California, San Diego 500
Testing effectiveness (Phase 2)Ended earlyNCT03886493What this trial is testingNeoadjuvant Dupilumab in Men With Localized High-Risk Prostate CancerWho this might be right forProstate Cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 7
Large-scale testing (Phase 3)Active Not RecruitingNCT02446444What this trial is testingEnzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate CancerWho this might be right forProstatic Neoplasms University of Sydney 802
Not applicableLooking for participantsNCT01194648What this trial is testingFocal Therapy for Prostate Cancer Using HIFUWho this might be right forMale Erectile DisorderProstate CancerTherapy-related Toxicity+1 more University College, London 354
Not applicableStudy completedNCT05303558What this trial is testingHigh Risk Localized Prostate Cancer Participants Treated With Radical Prostatectomy and Perioperative Hormonal TherapyWho this might be right forHigh Risk Localized Prostate Cancer Johnson & Johnson International (Singapore) Pte. Ltd. 221
Not applicableLooking for participantsNCT04831983What this trial is testingABlative Radiotherapy (for) Unfavorable Prostate TumorsWho this might be right forProstate Cancer University of Milano Bicocca 30